MK-0703 is a selective cyclooxygenase-2 inhibitor investigated for the treatment of acute pain and inflammation. MK-0703 at 50 and 100 mg was shown to be efficacious in the treatment of postoperative dental pain and were indistinguishable from the active comparator, ibuprofen 400 mg. References: Schwartz JI, Kotey PN, Fricke JR Jr, Gottesdiener K. MK-0703 (a cyclooxygenase-2 inhibitor) in acute pain associated with dental surgery: a randomized, double-blind, placebo- and active comparator-controlled dose-ranging study. Am J Ther. 2007 Jan-Feb;14(1):13-9. PubMed PMID: 17303970.

纯度：≥98%

CAS：189954-93-6